Author:
Dey Bimalangshu R.,Chung Stephen S.,Spitzer Thomas R.,Zheng Hui,MacGillivray Thomas E.,Seldin David C.,McAfee Steven,Ballen Karen,Attar Eyal,Wang Thomas,Shin Jordan,Newton-Cheh Christopher,Moore Stephanie,Sanchorawala Vaishali,Skinner Martha,Madsen Joren C.,Semigran Marc J.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference20 articles.
1. Treatment of 100 patients with primary amyloidosis: A randomized trial of melphalan, prednisone, and colchicine versus colchicine only.;Skinner;Am J Med,1996
2. A trial of three regimens for primary amyloidosis: Colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine.;Kyle;N Engl J Med,1997
3. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases.;Kyle;Semin Hematol,1995
4. Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis.;Gertz;J Clin Oncol,1999
5. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: An 8-year study.;Skinner;Ann Intern Med,2004
Cited by
99 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献